Skip to main content
Top
Published in: BMC Medical Genetics 1/2011

Open Access 01-12-2011 | Research article

Variable expressivity of FGF3 mutations associated with deafness and LAMM syndrome

Authors: Saima Riazuddin, Zubair M Ahmed, Rashmi S Hegde, Shaheen N Khan, Idrees Nasir, Uzma Shaukat, Sheikh Riazuddin, John A Butman, Andrew J Griffith, Thomas B Friedman, Byung Yoon Choi

Published in: BMC Medical Genetics | Issue 1/2011

Login to get access

Abstract

Background

Recessive mutations of fibroblast growth factor 3 (FGF3) can cause LAMM syndrome (OMIM 610706), characterized by fully penetrant complete labyrinthine aplasia, microtia and microdontia.

Methods

We performed a prospective molecular genetic and clinical study of families segregating hearing loss linked to FGF3 mutations. Ten affected individuals from three large Pakistani families segregating FGF3 mutations were imaged with CT, MRI, or both to detect inner ear abnormalities. We also modeled the three dimensional structure of FGF3 to better understand the structural consequences of the three missense mutations.

Results

Two families segregated reported mutations (p.R104X and p.R95W) and one family segregated a novel mutation (p.R132GfsX26) of FGF3. All individuals homozygous for p.R104X or p.R132GfsX26 had fully penetrant features of LAMM syndrome. However, recessive p.R95W mutations were associated with nearly normal looking auricles and variable inner ear structural phenotypes, similar to that reported for a Somali family also segregating p.R95W. This suggests that the mild phenotype is not entirely due to genetic background. Molecular modeling result suggests a less drastic effect of p.R95W on FGF3 function compared with known missense mutations detected in fully penetrant LAMM syndrome. Since we detected significant intrafamilial variability of the inner ear structural phenotype in the family segregating p.R95W, we also sequenced FGF10 as a likely candidate for a modifier. However, we did not find any sequence variation, pointing out that a larger sample size will be needed to map and identify a modifier. We also observed a mild to moderate bilateral conductive hearing loss in three carriers of p.R95W, suggesting either a semi-dominant effect of this mutant allele of FGF3, otitis media, or a consequence of genetic background in these three family members.

Conclusions

We noted a less prominent dental and external ear phenotype in association with the homozygous p.R95W. Therefore, we conclude that the manifestations of recessive FGF3 mutations range from fully penetrant LAMM syndrome to deafness with residual inner ear structures and, by extension, with minimal syndromic features, an observation with implications for cochlear implantation candidacy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Morton CC, Nance WE: Newborn hearing screening--a silent revolution. N Engl J Med. 2006, 354 (20): 2151-2164. 10.1056/NEJMra050700.CrossRefPubMed Morton CC, Nance WE: Newborn hearing screening--a silent revolution. N Engl J Med. 2006, 354 (20): 2151-2164. 10.1056/NEJMra050700.CrossRefPubMed
2.
go back to reference Smith RJ, Bale JF, White KR: Sensorineural hearing loss in children. Lancet. 2005, 365 (9462): 879-890. 10.1016/S0140-6736(05)71047-3.CrossRefPubMed Smith RJ, Bale JF, White KR: Sensorineural hearing loss in children. Lancet. 2005, 365 (9462): 879-890. 10.1016/S0140-6736(05)71047-3.CrossRefPubMed
3.
go back to reference Bamiou DE, Phelps P, Sirimanna T: Temporal bone computed tomography findings in bilateral sensorineural hearing loss. Arch Dis Child. 2000, 82 (3): 257-260. 10.1136/adc.82.3.257.CrossRefPubMedPubMedCentral Bamiou DE, Phelps P, Sirimanna T: Temporal bone computed tomography findings in bilateral sensorineural hearing loss. Arch Dis Child. 2000, 82 (3): 257-260. 10.1136/adc.82.3.257.CrossRefPubMedPubMedCentral
4.
go back to reference Mafong DD, Shin EJ, Lalwani AK: Use of laboratory evaluation and radiologic imaging in the diagnostic evaluation of children with sensorineural hearing loss. Laryngoscope. 2002, 112 (1): 1-7. 10.1097/00005537-200201000-00001.CrossRefPubMed Mafong DD, Shin EJ, Lalwani AK: Use of laboratory evaluation and radiologic imaging in the diagnostic evaluation of children with sensorineural hearing loss. Laryngoscope. 2002, 112 (1): 1-7. 10.1097/00005537-200201000-00001.CrossRefPubMed
5.
go back to reference Wu CC, Chen YS, Chen PJ, Hsu CJ: Common clinical features of children with enlarged vestibular aqueduct and Mondini dysplasia. Laryngoscope. 2005, 115 (1): 132-137. 10.1097/01.mlg.0000150691.85387.3f.CrossRefPubMed Wu CC, Chen YS, Chen PJ, Hsu CJ: Common clinical features of children with enlarged vestibular aqueduct and Mondini dysplasia. Laryngoscope. 2005, 115 (1): 132-137. 10.1097/01.mlg.0000150691.85387.3f.CrossRefPubMed
6.
go back to reference Jackler RK, Luxford WM, House WF: Congenital malformations of the inner ear: a classification based on embryogenesis. Laryngoscope. 1987, 97 (3 Pt 2 Suppl 40): 2-14.PubMed Jackler RK, Luxford WM, House WF: Congenital malformations of the inner ear: a classification based on embryogenesis. Laryngoscope. 1987, 97 (3 Pt 2 Suppl 40): 2-14.PubMed
7.
go back to reference Alsmadi O, Meyer BF, Alkuraya F, Wakil S, Alkayal F, Al-Saud H, Ramzan K, Al-Sayed M: Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3). Eur J Hum Genet. 2009, 17 (1): 14-21. 10.1038/ejhg.2008.141.CrossRefPubMed Alsmadi O, Meyer BF, Alkuraya F, Wakil S, Alkayal F, Al-Saud H, Ramzan K, Al-Sayed M: Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3). Eur J Hum Genet. 2009, 17 (1): 14-21. 10.1038/ejhg.2008.141.CrossRefPubMed
8.
go back to reference Lindsay JR: Profound childhood deafness. Inner ear pathology. Ann Oto Rhinol Laryngology. 1973, 82 (Suppl 5): 1-121. Lindsay JR: Profound childhood deafness. Inner ear pathology. Ann Oto Rhinol Laryngology. 1973, 82 (Suppl 5): 1-121.
9.
go back to reference Tekin M, Hismi BO, Fitoz S, Ozdag H, Cengiz FB, Sirmaci A, Aslan I, Inceoglu B, Yuksel-Konuk EB, Yilmaz ST, et al: Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia. Am J Hum Genet. 2007, 80 (2): 338-344. 10.1086/510920.CrossRefPubMed Tekin M, Hismi BO, Fitoz S, Ozdag H, Cengiz FB, Sirmaci A, Aslan I, Inceoglu B, Yuksel-Konuk EB, Yilmaz ST, et al: Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia. Am J Hum Genet. 2007, 80 (2): 338-344. 10.1086/510920.CrossRefPubMed
10.
go back to reference Tekin M, Ozturkmen Akay H, Fitoz S, Birnbaum S, Cengiz FB, Sennaroglu L, Incesulu A, Yuksel Konuk EB, Hasanefendioglu Bayrak A, Senturk S, et al: Homozygous FGF3 mutations result in congenital deafness with inner ear agenesis, microtia, and microdontia. Clin Genet. 2008, 73 (6): 554-565. 10.1111/j.1399-0004.2008.01004.x.CrossRefPubMed Tekin M, Ozturkmen Akay H, Fitoz S, Birnbaum S, Cengiz FB, Sennaroglu L, Incesulu A, Yuksel Konuk EB, Hasanefendioglu Bayrak A, Senturk S, et al: Homozygous FGF3 mutations result in congenital deafness with inner ear agenesis, microtia, and microdontia. Clin Genet. 2008, 73 (6): 554-565. 10.1111/j.1399-0004.2008.01004.x.CrossRefPubMed
11.
go back to reference Jorgensen MB, Kristensen HK, Buch NH: Thalidomide-Induced Aplasia of the Inner Ear. J Laryngo Oto. 1964, 78: 1095-1101.CrossRef Jorgensen MB, Kristensen HK, Buch NH: Thalidomide-Induced Aplasia of the Inner Ear. J Laryngo Oto. 1964, 78: 1095-1101.CrossRef
12.
go back to reference Kavanagh KT, Magill HL: Michel dysplasia. Common cavity inner ear deformity. Pediatr Radiol. 1989, 19 (5): 343-345. 10.1007/BF02467313.CrossRefPubMed Kavanagh KT, Magill HL: Michel dysplasia. Common cavity inner ear deformity. Pediatr Radiol. 1989, 19 (5): 343-345. 10.1007/BF02467313.CrossRefPubMed
13.
go back to reference Hersh JH, Ganzel TM, Fellows RA: Michel's anomaly, type I microtia and microdontia. Ear Nose Throat J. 1991, 70 (3): 155-157.PubMed Hersh JH, Ganzel TM, Fellows RA: Michel's anomaly, type I microtia and microdontia. Ear Nose Throat J. 1991, 70 (3): 155-157.PubMed
14.
go back to reference Marsot-Dupuch K, Dominguez-Brito A, Ghasli K, Chouard CH: CT and MR findings of Michel anomaly: inner ear aplasia. Am J Neuroradiol. 1999, 20 (2): 281-284.PubMed Marsot-Dupuch K, Dominguez-Brito A, Ghasli K, Chouard CH: CT and MR findings of Michel anomaly: inner ear aplasia. Am J Neuroradiol. 1999, 20 (2): 281-284.PubMed
15.
go back to reference Daneshi A, Farhadi M, Asghari A, Emamjomeh H, Abbasalipour P, Hasanzadeh S: Three familial cases of Michel's aplasia. Otol Neurotol. 2002, 23 (3): 346-348. 10.1097/00129492-200205000-00020.CrossRefPubMed Daneshi A, Farhadi M, Asghari A, Emamjomeh H, Abbasalipour P, Hasanzadeh S: Three familial cases of Michel's aplasia. Otol Neurotol. 2002, 23 (3): 346-348. 10.1097/00129492-200205000-00020.CrossRefPubMed
16.
go back to reference Ramsebner R, Ludwig M, Parzefall T, Lucas T, Baumgartner WD, Bodamer O, Cengiz FB, Schoefer C, Tekin M, Frei K: A FGF3 mutation associated with differential inner ear malformation, microtia, and microdontia. Laryngoscope. 2010, 120 (2): 359-364.PubMed Ramsebner R, Ludwig M, Parzefall T, Lucas T, Baumgartner WD, Bodamer O, Cengiz FB, Schoefer C, Tekin M, Frei K: A FGF3 mutation associated with differential inner ear malformation, microtia, and microdontia. Laryngoscope. 2010, 120 (2): 359-364.PubMed
17.
go back to reference Alvarez Y, Alonso MT, Vendrell V, Zelarayan LC, Chamero P, Theil T, Bosl MR, Kato S, Maconochie M, Riethmacher D, et al: Requirements for FGF3 and FGF10 during inner ear formation. Development. 2003, 130 (25): 6329-6338. 10.1242/dev.00881.CrossRefPubMed Alvarez Y, Alonso MT, Vendrell V, Zelarayan LC, Chamero P, Theil T, Bosl MR, Kato S, Maconochie M, Riethmacher D, et al: Requirements for FGF3 and FGF10 during inner ear formation. Development. 2003, 130 (25): 6329-6338. 10.1242/dev.00881.CrossRefPubMed
18.
go back to reference Hatch EP, Noyes CA, Wang X, Wright TJ, Mansour SL: Fgf3 is required for dorsal patterning and morphogenesis of the inner ear epithelium. Development. 2007, 134 (20): 3615-3625. 10.1242/dev.006627.CrossRefPubMedPubMedCentral Hatch EP, Noyes CA, Wang X, Wright TJ, Mansour SL: Fgf3 is required for dorsal patterning and morphogenesis of the inner ear epithelium. Development. 2007, 134 (20): 3615-3625. 10.1242/dev.006627.CrossRefPubMedPubMedCentral
19.
go back to reference Mansour SL, Goddard JM, Capecchi MR: Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development. 1993, 117 (1): 13-28.PubMed Mansour SL, Goddard JM, Capecchi MR: Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development. 1993, 117 (1): 13-28.PubMed
20.
go back to reference Wilkinson DG, Peters G, Dickson C, McMahon AP: Expression of the FGF-related proto-oncogene int-2 during gastrulation and neurulation in the mouse. EMBO J. 1988, 7 (3): 691-695.PubMedPubMedCentral Wilkinson DG, Peters G, Dickson C, McMahon AP: Expression of the FGF-related proto-oncogene int-2 during gastrulation and neurulation in the mouse. EMBO J. 1988, 7 (3): 691-695.PubMedPubMedCentral
21.
go back to reference Khan SY, Riazuddin S, Tariq M, Anwar S, Shabbir MI, Riazuddin SA, Khan SN, Husnain T, Ahmed ZM, Friedman TB, et al: Autosomal recessive nonsyndromic deafness locus DFNB63 at chromosome 11q13.2-q13.3. Hum Genet. 2007, 120 (6): 789-793. 10.1007/s00439-006-0275-1.CrossRefPubMed Khan SY, Riazuddin S, Tariq M, Anwar S, Shabbir MI, Riazuddin SA, Khan SN, Husnain T, Ahmed ZM, Friedman TB, et al: Autosomal recessive nonsyndromic deafness locus DFNB63 at chromosome 11q13.2-q13.3. Hum Genet. 2007, 120 (6): 789-793. 10.1007/s00439-006-0275-1.CrossRefPubMed
22.
go back to reference Ahmed ZM, Riazuddin S, Bernstein SL, Ahmed Z, Khan S, Griffith AJ, Morell RJ, Friedman TB, Riazuddin S, Wilcox ER: Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. Am J Hum Genet. 2001, 69 (1): 25-34. 10.1086/321277.CrossRefPubMedPubMedCentral Ahmed ZM, Riazuddin S, Bernstein SL, Ahmed Z, Khan S, Griffith AJ, Morell RJ, Friedman TB, Riazuddin S, Wilcox ER: Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. Am J Hum Genet. 2001, 69 (1): 25-34. 10.1086/321277.CrossRefPubMedPubMedCentral
23.
go back to reference Ahmed ZM, Masmoudi S, Kalay E, Belyantseva IA, Mosrati MA, Collin RW, Riazuddin S, Hmani-Aifa M, Venselaar H, Kawar MN, et al: Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans. Nat Genet. 2008, 40 (11): 1335-1340. 10.1038/ng.245.CrossRefPubMedPubMedCentral Ahmed ZM, Masmoudi S, Kalay E, Belyantseva IA, Mosrati MA, Collin RW, Riazuddin S, Hmani-Aifa M, Venselaar H, Kawar MN, et al: Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans. Nat Genet. 2008, 40 (11): 1335-1340. 10.1038/ng.245.CrossRefPubMedPubMedCentral
24.
go back to reference Du X, Schwander M, Moresco EM, Viviani P, Haller C, Hildebrand MS, Pak K, Tarantino L, Roberts A, Richardson H, et al: A catechol-O-methyltransferase that is essential for auditory function in mice and humans. P Natl Acad Sci USA. 2008, 105 (38): 14609-14614. 10.1073/pnas.0807219105.CrossRef Du X, Schwander M, Moresco EM, Viviani P, Haller C, Hildebrand MS, Pak K, Tarantino L, Roberts A, Richardson H, et al: A catechol-O-methyltransferase that is essential for auditory function in mice and humans. P Natl Acad Sci USA. 2008, 105 (38): 14609-14614. 10.1073/pnas.0807219105.CrossRef
25.
go back to reference Arnold K, Bordoli L, Kopp J, Schwede T: The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics. 2006, 22 (2): 195-201. 10.1093/bioinformatics/bti770.CrossRefPubMed Arnold K, Bordoli L, Kopp J, Schwede T: The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics. 2006, 22 (2): 195-201. 10.1093/bioinformatics/bti770.CrossRefPubMed
26.
go back to reference Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, Aaronson SA, Mohammadi M: Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. P Natl Acad Sci USA. 2003, 100 (5): 2266-2271. 10.1073/pnas.0436500100.CrossRef Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, Aaronson SA, Mohammadi M: Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. P Natl Acad Sci USA. 2003, 100 (5): 2266-2271. 10.1073/pnas.0436500100.CrossRef
27.
go back to reference Weerda H: Classification of congenital deformities of the auricle. Facial Plast Surg. 1988, 5 (5): 385-388. 10.1055/s-2008-1064778.CrossRefPubMed Weerda H: Classification of congenital deformities of the auricle. Facial Plast Surg. 1988, 5 (5): 385-388. 10.1055/s-2008-1064778.CrossRefPubMed
28.
go back to reference Lee J, Blaber M: Structural basis of conserved cysteine in the fibroblast growth factor family: evidence for a vestigial half-cystine. J Mol Biol. 2009, 393 (1): 128-139. 10.1016/j.jmb.2009.08.007.CrossRefPubMed Lee J, Blaber M: Structural basis of conserved cysteine in the fibroblast growth factor family: evidence for a vestigial half-cystine. J Mol Biol. 2009, 393 (1): 128-139. 10.1016/j.jmb.2009.08.007.CrossRefPubMed
29.
go back to reference Ortega S, Schaeffer MT, Soderman D, DiSalvo J, Linemeyer DL, Gimenez-Gallego G, Thomas KA: Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor. J Biol Chem. 1991, 266 (9): 5842-5846.PubMed Ortega S, Schaeffer MT, Soderman D, DiSalvo J, Linemeyer DL, Gimenez-Gallego G, Thomas KA: Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor. J Biol Chem. 1991, 266 (9): 5842-5846.PubMed
30.
go back to reference Harmer NJ, Pellegrini L, Chirgadze D, Fernandez-Recio J, Blundell TL: The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. Biochemistry. 2004, 43 (3): 629-640. 10.1021/bi035320k.CrossRefPubMed Harmer NJ, Pellegrini L, Chirgadze D, Fernandez-Recio J, Blundell TL: The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity. Biochemistry. 2004, 43 (3): 629-640. 10.1021/bi035320k.CrossRefPubMed
31.
go back to reference Luo Y, Lu W, Mohamedali KA, Jang JH, Jones RB, Gabriel JL, Kan M, McKeehan WL: The glycine box: a determinant of specificity for fibroblast growth factor. Biochemistry. 1998, 37 (47): 16506-16515. 10.1021/bi9816599.CrossRefPubMed Luo Y, Lu W, Mohamedali KA, Jang JH, Jones RB, Gabriel JL, Kan M, McKeehan WL: The glycine box: a determinant of specificity for fibroblast growth factor. Biochemistry. 1998, 37 (47): 16506-16515. 10.1021/bi9816599.CrossRefPubMed
32.
go back to reference Pellegrini L: Role of heparan sulfate in fibroblast growth factor signalling: a structural view. Curr Opin Structural Biology. 2001, 11 (5): 629-634. 10.1016/S0959-440X(00)00258-X.CrossRef Pellegrini L: Role of heparan sulfate in fibroblast growth factor signalling: a structural view. Curr Opin Structural Biology. 2001, 11 (5): 629-634. 10.1016/S0959-440X(00)00258-X.CrossRef
33.
go back to reference Rohmann E, Brunner HG, Kayserili H, Uyguner O, Nurnberg G, Lew ED, Dobbie A, Eswarakumar VP, Uzumcu A, Ulubil-Emeroglu M, et al: Mutations in different components of FGF signaling in LADD syndrome. Nat Genet. 2006, 38 (4): 414-417. 10.1038/ng1757.CrossRefPubMed Rohmann E, Brunner HG, Kayserili H, Uyguner O, Nurnberg G, Lew ED, Dobbie A, Eswarakumar VP, Uzumcu A, Ulubil-Emeroglu M, et al: Mutations in different components of FGF signaling in LADD syndrome. Nat Genet. 2006, 38 (4): 414-417. 10.1038/ng1757.CrossRefPubMed
34.
go back to reference Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M: Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996, 271 (25): 15292-15297. 10.1074/jbc.271.25.15292.CrossRefPubMed Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M: Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996, 271 (25): 15292-15297. 10.1074/jbc.271.25.15292.CrossRefPubMed
35.
go back to reference Mohammadi M, Olsen SK, Ibrahimi OA: Structural basis for fibroblast growth factor receptor activation. Cytokine Growth F R. 2005, 16 (2): 107-137. 10.1016/j.cytogfr.2005.01.008.CrossRef Mohammadi M, Olsen SK, Ibrahimi OA: Structural basis for fibroblast growth factor receptor activation. Cytokine Growth F R. 2005, 16 (2): 107-137. 10.1016/j.cytogfr.2005.01.008.CrossRef
36.
go back to reference Inan UU, Yilmaz MD, Demir Y, Degirmenci B, Ermis SS, Ozturk F: Characteristics of lacrimo-auriculo-dento-digital (LADD) syndrome: case report of a family and literature review. Int J Pediatr Otorhinolaryngol. 2006, 70 (7): 1307-1314. 10.1016/j.ijporl.2005.12.015.CrossRefPubMed Inan UU, Yilmaz MD, Demir Y, Degirmenci B, Ermis SS, Ozturk F: Characteristics of lacrimo-auriculo-dento-digital (LADD) syndrome: case report of a family and literature review. Int J Pediatr Otorhinolaryngol. 2006, 70 (7): 1307-1314. 10.1016/j.ijporl.2005.12.015.CrossRefPubMed
37.
go back to reference Gregory-Evans CY, Moosajee M, Hodges MD, Mackay DS, Game L, Vargesson N, Bloch-Zupan A, Ruschendorf F, Santos-Pinto L, Wackens G, et al: SNP genome scanning localizes oto-dental syndrome to chromosome 11q13 and microdeletions at this locus implicate FGF3 in dental and inner-ear disease and FADD in ocular coloboma. Hum Mol Genet. 2007, 16 (20): 2482-2493. 10.1093/hmg/ddm204.CrossRefPubMed Gregory-Evans CY, Moosajee M, Hodges MD, Mackay DS, Game L, Vargesson N, Bloch-Zupan A, Ruschendorf F, Santos-Pinto L, Wackens G, et al: SNP genome scanning localizes oto-dental syndrome to chromosome 11q13 and microdeletions at this locus implicate FGF3 in dental and inner-ear disease and FADD in ocular coloboma. Hum Mol Genet. 2007, 16 (20): 2482-2493. 10.1093/hmg/ddm204.CrossRefPubMed
38.
go back to reference Pirvola U, Spencer-Dene B, Xing-Qun L, Kettunen P, Thesleff I, Fritzsch B, Dickson C, Ylikoski J: FGF/FGFR-2(IIIb) signaling is essential for inner ear morphogenesis. J Neurosci. 2000, 20 (16): 6125-6134.PubMed Pirvola U, Spencer-Dene B, Xing-Qun L, Kettunen P, Thesleff I, Fritzsch B, Dickson C, Ylikoski J: FGF/FGFR-2(IIIb) signaling is essential for inner ear morphogenesis. J Neurosci. 2000, 20 (16): 6125-6134.PubMed
Metadata
Title
Variable expressivity of FGF3 mutations associated with deafness and LAMM syndrome
Authors
Saima Riazuddin
Zubair M Ahmed
Rashmi S Hegde
Shaheen N Khan
Idrees Nasir
Uzma Shaukat
Sheikh Riazuddin
John A Butman
Andrew J Griffith
Thomas B Friedman
Byung Yoon Choi
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2011
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-12-21

Other articles of this Issue 1/2011

BMC Medical Genetics 1/2011 Go to the issue